Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Medtronic
Deloitte
Chubb
Merck
Johnson and Johnson
Chinese Patent Office
Citi

Generated: December 17, 2018

DrugPatentWatch Database Preview

OLUX Drug Profile

« Back to Dashboard

When do Olux patents expire, and what generic alternatives are available?

Olux is a drug marketed by Mylan Pharms Inc and is included in two NDAs. There are four patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in OLUX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

Drug patent expirations by year for OLUX
Pharmacology for OLUX
Medical Subject Heading (MeSH) Categories for OLUX
Synonyms for OLUX
(11b,16b)-21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione
(1R,2S,10S,11S,13S,14R,15S,17S)-14-(2-CHLOROACETYL)-1-FLUORO-17-HYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL PROPANOATE
[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
122C467
21-chloro-9-fluoro-11 beta-hydroxy-16 beta-methylpregna-1,4-diene-3,20-dione 17-propionate
21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)-
21-Chloro-9-fluoro-11b,17-dihydroxy-16b-methylpregna-1,4-diene-3,20-dione 17-propionate
21-chloro-9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate
21-Chloro-9-fluoro-11beta-hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate
21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate
21-Chloro-9alpha-fluoro-11beta,17alpha-dihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17-Propionate
25122-46-7
779619577M
AB00383081_11
AB00383081-10
AB1009262
AC-17990
AC1L1OG9
AC1Q3T8C
AKOS015951278
Ambap25122-46-7
AMOT0927
AN-14318
AS-12555
BCP0726000094
BCP9000539
BDBM39347
BRD-K10799896-001-10-6
Butavate
C-22667
C25H32ClFO5
CAS-25122-46-7
CC-25914
CCG-220781
CCI 4725
CCI-4725
CGP 9555
CHEBI:31414
CHEMBL1159650
cid_32798
Clarelux
Clobesol
Clobestasol propionate
clobetasol 17-propanoate
Clobetasol 17-propionate
Clobetasol for peak identification, European Pharmacopoeia (EP) Reference Standard
CLOBETASOL PROPIONATE
CLOBETASOL PROPIONATE (EMOLLIENT)
Clobetasol propionate (JP17/USP)
Clobetasol propionate [USAN:JAN]
Clobetasol propionate [USAN:USP:JAN]
Clobetasol propionate E
Clobetasol propionate gel
Clobetasol propionate, analytical standard
Clobetasol propionate, European Pharmacopoeia (EP) Reference Standard
Clobetasol Propionate, Pharmaceutical Secondary Standard; Certified Reference Material
Clobetasol propionate, United States Pharmacopeia (USP) Reference Standard
Clobetasole propionate
Clobetasolpropionat mikron.
Clobetasolpropionate
Clobex
Cormax
Cormax (TN)
CPD000058745
CS-2594
D01272
DB01013
Dermoval
Dermovate
Dermoxinale
DSSTox_CID_25907
DSSTox_GSID_45907
DSSTox_RID_81219
DTXSID6045907
EBD6220
EINECS 246-634-3
Embeline
Embeline E
GR 2/925
GTPL7062
HMS2090A04
HMS2230H08
HMS3259A10
HY-13600
Impoyz
LS-118433
MFCD00058499
MLS000028708
MLS001076345
NC00551
NCGC00023373-03
NCGC00023373-04
NCGC00095078-01
Olux E
OLUX FOAM
Olux-E
Opera_ID_1470
PL000420
Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-beta,17-dihydroxy-16-beta-methyl-, 17-propionate
Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-beta,17-dihydroxy-16-beta-methyl-,17-propionate
Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy- 16-methyl-17-(1-oxopropoxy)-, (11ss,16ss)-
Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11beta,16beta)-
Propionic acid clobetasol
s2584
SCHEMBL3997
SMR000058745
SR-01000000280
SR-01000000280-4
Temovate
Temovate E
Tox21_111414
Tox21_111414_1
UNII-779619577M
Yugofin
ZINC3977767

US Patents and Regulatory Information for OLUX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc OLUX clobetasol propionate AEROSOL, FOAM;TOPICAL 021142-001 May 26, 2000 AB1 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc OLUX E clobetasol propionate AEROSOL, FOAM;TOPICAL 022013-001 Jan 12, 2007 AB2 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Mylan Pharms Inc OLUX E clobetasol propionate AEROSOL, FOAM;TOPICAL 022013-001 Jan 12, 2007 AB2 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for OLUX
Drugname Dosage Strength RLD Date
➤ Subscribe Emulsion Foam 0.05% ➤ Subscribe ➤ Try a Free Trial
➤ Subscribe Topical Foam 0.05% ➤ Subscribe ➤ Try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Medtronic
Deloitte
Chubb
Merck
Johnson and Johnson
Chinese Patent Office
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.